Legal battles intensify over telehealth abortion-pill access

States and conservative groups are suing to overturn FDA rules that allow mifepristone via telehealth, arguing such access clashes with bans in many states. Federal cases involving Louisiana, Texas and others are pressing the FDA as courts weigh whether prescribing rules are too restrictive, with a status update deadline of Oct. 7 in some matters. Even if limits tighten, abortion pills could still be accessible through alternatives like misoprostol, sparking debates about state control vs. federal oversight and the future of telehealth for this medication.